Page 21 - Client Alert News Today

On 14 December 2022, the Securities and Exchange Commission (SEC) proposed four separate rulemakings under the Securities Exchange Act of…

2022 was a big year for the pharmaceutical and biotechnology sectors. Novel technologies emerged at a rapid clip. The Food and Drug Administration (“FDA” or the “Agency”) approved over...

On January 5, 2023, the Federal Trade Commission (FTC) issued a Notice of Proposed Rulemaking (Proposed Rule) regarding non-compete agreements. The Proposed Rule would prohibit...

The New York Department of Financial Services NYDFS recently announced it has entered into a Consent Order with an insurance agency for alleged violations of New York’s Cybersecurity Regulation. The Insurance Agency agreed to pay a $1.9 million penalty to the NYDFS.

United Kingdom Financial Conduct Authority UK FCA announced Zombie USD LIBOR from July 1st through September 30, 2024, 1-Month and 6-Month Zombie Sterling LIBOR to cease March 31st, 3-Month Zombie Sterling LIBOR continue through March 29, 2024, Zombie Yen LIBOR ceased.

Last year, the United Kingdom Financial Conduct Authority (UK FCA) announced the following: - ‘Zombie’ USD LIBOR for proposed use from July 1, 2023, through September 30, 2024,...

The Modernization of Cosmetics Regulation Act of 2022 (“MOCRA”) was signed into law alongside other reforms to the Federal Food, Drug, and Cosmetic Act (“FD&C Act”) on December 29,...

The Food and Drug Administration (“FDA” or the “Agency”) user fee negotiations may have hit an iceberg, but it did not sink all the legislative riders that accompanied this summer’s...

California continues to serve as the primary driver of privacy law in the United States, but other state laws now warrant compliance. The California Privacy Rights Act (CPRA), effective...

As discussed in a recent Client Alert, companies doing business in Maine are facing a fast-approaching January 1, 2023 deadline to begin reporting the use of PFAS. Maine’s Department...